| Baseline | Actual values after baseline | Median fold change to baseline | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | Day15 | Day30 | Day45 | Day75 |  |  |  |  | ||||
Clinical outcome | N | Median | Q1-Q3 | Median | Q1-Q3 | Median | Q1-Q3 | Median | Q1-Q3 | Median | Q1-Q3 | Day15 | Day30 | Day45 | Day75 |
Disease progression | 9 | 61.1 | 39.5-120.4 | 132.3 | 75.7-341.2 | 145.8 | 96.6-553.3 | 576.8 | 54.5-827.0 | 344.0 | 191.9-1071.0 | 2.8 | 3.9 | 8.9 | 5.4 |
Clinical benefit | 27 | 149.0 | 97.7-535.6 | 179.5 | 80.5-337.5 | 215.2 | 87.4-380.6 | 241.7 | 111.2-555.5 | 260.1 | 120.6-637.4 | 1.0 | 1.0 | 0.9 | 0.9 |
p-value | 0.021 | 0.768 | 0.951 | 0.726 | 0.374 | 0.0002 | 0.002 | 0.003 | 0.025 |